drugset / Trial / NCT02561494

Postoperative Analgesic Effect of Nefopam

NCT02561494

RandomizedParallel-groupDouble-blindPrevention

Summary

Nefopam will be administered to the patients undergoing laparoscopic gastrectomy under the total intravenous anesthesia (TIVA). The investigators will evaluate whether the nefopam can decrease the total amount of remifentanil administered during the operation, which will reduce the acute opioid tolerance and following consumption of fentanyl during postoperative period.

Timeline

Start
2015-06
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Nefopam Small molecule 20 mg Intravenous

Indications